Search

everythinglearnresearchcommunity

for

Search:↓

New BPH treatments have low sexual dysfunction risk but may not improve urinary symptoms as much as traditional surgery.

Platelet-rich plasma can improve erectile function in older individuals by reducing prostate enlargement.

Persistent ED in Propecia users is not due to abnormal blood flow.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Balding people may have higher heart disease risk.

Hair loss in young men in Central India is linked to severe heart disease.

Hair loss linked to heart disease in young men.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Early balding, premature graying, and hair thinning can predict heart disease in young Asian males.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Early hair loss in men and women may indicate a higher risk of heart disease and metabolic problems.

Premature hair loss doesn't increase the risk of metabolic syndrome.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Spironolactone treatment increases the amount of testosterone available in the body.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Finasteride reduces prostate cancer risk but may affect ejaculatory volume and requires careful consideration for young men.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.